EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A decision‐making framework for genomic testing in paediatric nephrology

Inez Beadell iD, Catherine Quinlan iD

Journal of Paediatrics and Child Health · 2023

DOI: 10.1111/jpc.16514 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Paediatrics and Child Health, 2023. Verfasst von Inez Beadell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Nephrology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Technological advances and increased access have led to genomics expanding beyond the genetics clinic. Consequently, nephrologists can now order genomic testing for their patients. Consistent decision‐making around patient and test selection is required to ensure equitable access while maximising the utility of genomic testing. However, there are currently no frameworks to guide decision‐making for testing in this context. We aimed to develop an ethical decision‐making framework for genomic testing in paediatric nephrology.

Methods

A three‐stage approach was used: (i) review of the literature on decision‐making for genomic testing in nephrology and other disciplines; (ii) ethnographic observation of approaches to genomic testing in the general nephrology and renal genetics clinics at an Australian paediatric hospital; (iii) review and revision of the framework with key stakeholders, including clinical geneticists, genetic counsellors, paediatric nephrologists and families from the renal genetics service. The initial framework was modified until consensus from key stakeholders was reached.

Results

A decision‐making framework was created with questions designed to explore the impact of genomic testing on patient management, clinical validity, patient characteristics, alternatives to genomic testing, genetic counselling, resource availability, implications for family members, psychosocial considerations, patient autonomy, research, support services and insurance. Case studies were developed to demonstrate the framework's application.

Conclusions

This framework was designed to guide decisions around patient selection for genomic testing in nephrology in the Australian health‐care setting, with potential utility in other institutions and medical disciplines. It may help facilitate consistent approaches to genomic testing, to maximise equity and utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrologyChildHumansAustraliaAmbulatory Care FacilitiesGenomicsGenetic Testing

Stichwörter der Autor:innen

genomic medicinenephrologypaediatricspatient selection

Autor:innen und Institutionen

  • Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • Kidney Flagship, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Department of Paediatric Nephrology, The Royal Children's Hospital, Melbourne, Victoria, Australia.

ORCID-Profile: Inez Beadell, Catherine Quinlan

Zitieren

APA

Beadell, I., & Quinlan, C. (2023). A decision‐making framework for genomic testing in paediatric nephrology. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16514

Vancouver

Beadell I, Quinlan C. A decision‐making framework for genomic testing in paediatric nephrology. Journal of Paediatrics and Child Health. 2023. doi:10.1111/jpc.16514

BibTeX
@article{Beadell2023,
  author = {Beadell, Inez and Quinlan, Catherine},
  title = {A decision‐making framework for genomic testing in paediatric nephrology},
  journal = {Journal of Paediatrics and Child Health},
  year = {2023},
  doi = {10.1111/jpc.16514}
}
Kostenlos starten →